- Taro Pharmaceutical (NYSE:TARO): FQ3 EPS of $3.33.
- Revenue of $237.7M (+11.3% Y/Y).
- Press Release
Taro Pharmaceutical reports FQ3 earnings
Recommended For You
About TARO Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| TARO | - | - |
| Taro Pharmaceutical Industries Ltd. | ||